TuHURA Biosciences (TuHURA Biosciences) Change In Inventory : $0.00 Mil (TTM As of Dec. 2022)

View and export this data going back to 2050. Start your Free Trial

What is TuHURA Biosciences Change In Inventory?

TuHURA Biosciences's change in inventory for the quarter that ended in Dec. 2022 was $0.00 Mil. It means TuHURA Biosciences's inventory stayed the same from Dec. 2021 to Dec. 2022 .

TuHURA Biosciences's change in inventory for the fiscal year that ended in Dec. 2022 was $0.00 Mil. It means TuHURA Biosciences's inventory stayed the same from Dec. 2021 to Dec. 2022 .

TuHURA Biosciences's Total Inventories for the quarter that ended in Dec. 2022 was $0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

TuHURA Biosciences Change In Inventory Historical Data

The historical data trend for TuHURA Biosciences's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TuHURA Biosciences Change In Inventory Chart

TuHURA Biosciences Annual Data

Trend

Dec21

Dec22

Change In Inventory

TuHURA Biosciences Semi-Annual Data
	Dec21	Dec22
Change In Inventory	-	-

TuHURA Biosciences Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00 Mil.

TuHURA Biosciences (NAS:HURA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

TuHURA Biosciences's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 2
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

TuHURA Biosciences's Inventory Turnover for the quarter that ended in Dec. 2022 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

TuHURA Biosciences's Inventory to Revenue for the quarter that ended in Dec. 2022 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

TuHURA Biosciences Change In Inventory Related Terms

Thank you for viewing the detailed overview of TuHURA Biosciences's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

TuHURA Biosciences (TuHURA Biosciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TuHURA Biosciences Inc (NAS:HURA) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

N/A

Address

10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612

Website

TuHURA Biosciences Inc is a clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment modulators to overcome resistance to current immunotherapies. The company's lead personalized cancer vaccine candidate, IFx-Hu2.0, is designed to prime the activation of the immune system to target and attack tumor cells by making them look like bacteria. Through an intratumoral injection of a gene coding for emm55, an immunogenic bacterial protein that is then expressed on the surface of tumor cells, the immune system is activated, providing a potent, multivalent systemic response against all neoantigens in a patient's tumor.

TuHURA Biosciences (TuHURA Biosciences) Headlines

No Headlines